Latest Jenny Chang Stories
A subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments and may not need chemotherapy.
In animal and patient studies, an experimental drug eliminated chemotherapy-resistant breast cancer stem cells â€“ the cells that remain after treatment that could potentially refuel tumor growth.
A subset of tumor cells that remain after a woman with breast cancer undergoes treatment with either anti-cancer or anti-hormone therapy shows a â€œgene signatureâ€ that could be used to define targets for developing new drugs against the disease
- The act of sweetening by admixture of some saccharine substance.